sitagliptin vi.rel pharma
vi.rel pharma s.r.l - sitagliptin - sitagliptin
sitagliptin teva
teva italia s.r.l. - sitagliptin - sitagliptin
sitagliptin biogaran
biogaran - sitagliptin - sitagliptin
sitagliptin adamed
adamed s.r.l. - sitagliptin - sitagliptin
sitagliptin sandoz
sandoz s.p.a. - sitagliptin - sitagliptin
sitagliptin liconsa
laboratorios liconsa, s.a. -
sitagliptin adamed pharma
adamed s.r.l. - sitagliptin - sitagliptin
sitagliptin doc generici
doc generici srl - sitagliptin - sitagliptin
sitagliptin diagonalis
galenicum health, s.l. - sitagliptin - sitagliptin
invokana
janssen-cilag international nv - canagliflozin - diabete mellito, tipo 2 - farmaci usati nel diabete - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 e 5.